Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

20 Nov 2017 07:00

RNS Number : 9048W
Xaar PLC
20 November 2017
 

Xaar plc

 

Trading Update

 

Xaar plc ("Xaar"), a world leader in industrial inkjet technology, provides a trading update today.

 

Further to our interim results statement in September and our earlier trading update in July, in which we indicated that growth in revenues from new products was expected to be second half weighted, the board now expects that revenue in the second half year will be broadly in line with the first half. The shortfall against previous expectations results largely from fewer than planned new printer installs of Xaar's 2001 Printhead, and slower than anticipated ramp up of the Xaar 1201 Printhead due to supply constraints.

In ceramics, the printhead replacement business is now anticipated to represent c.70% of revenues in 2017. The new 1003 Printhead has performed strongly in this market but as competition for new printer installs continues to intensify, we have seen more limited success with the 2001 product.

Demand for the 1201 Printhead remains strong, but due to supply constraints, we have not been able to fulfil all of the demand this year. We expect supply will improve with new capacity coming on stream next year, and we continue to expect significant growth in 2018.

Although disappointed by the revenue shortfall on the underlying business, we are encouraged by our reducing dependence on our legacy ceramics business, where there is little visibility, and increasing competitive pressure. Our 2020 vision and commitment to delivering growth from new products in new markets is undiminished but the timing of ramp up of the range of new products we have introduced remains less predictable. In 2017 we expect that 80% of our underlying revenues will be from the seven new products introduced and new businesses acquired in the last two years. This progress, together with our previously announced increased investment in sales and marketing, supports our continuing transformation to a more diversified and customer-centric company.

 

Enquiries:

 

Xaar plc

 

Doug Edwards, Chief Executive Officer

Lily Liu, Chief Financial Officer

 

+44 (0)1223 423 663 

Tulchan Communications

James Macey White

David Ison

Deborah Roney

+44 (0)20 7353 4200

 

About Xaar

Xaar is a world-leader in the development of inkjet technology and manufacture of piezoelectric drop-on-demand industrial printheads. The company also develops and sells ink systems, electronics and fluid optimisation services to accelerate inkjet system development and adoption. Xaar printheads incorporate patented technology, which delivers unbeatable performance when decorating, patterning, depositing functional coatings on, or adding structure to, a variety of industrial and consumer products. Today leading manufacturers worldwide, in sectors ranging from ceramics, wide-format graphics and labels to direct-to-shape packaging and decorative laminates, choose Xaar's printheads because they are extremely precise, exceptionally versatile, incredibly reliable, and designed for high-volume production. Additional information about Xaar is available at www.xaar.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVKLFFDFFZFBF
Date   Source Headline
3rd Oct 20164:33 pmRNSTotal Voting Rights
29th Sep 20169:25 amRNSBoard Changes
1st Sep 201610:44 amRNSTotal Voting Rights
26th Aug 201611:44 amRNSGrant of Options
24th Aug 20167:00 amRNS2016 Interim Results
1st Aug 20162:07 pmRNSTotal Voting Rights
13th Jul 20167:00 amRNSScheduled Trading Statement
12th Jul 20166:02 pmRNSHolding(s) in Company
1st Jul 201610:56 amRNSBlock listing Interim Review
1st Jul 201610:53 amRNSTotal Voting Rights
1st Jul 20169:32 amRNSNotice of Scheduled Trading Statement
1st Jul 20167:00 amRNSXAAR AQUIRES ENGINEERED PRINTING SOLUTIONS
2nd Jun 20163:00 pmRNSLAUNCH OF PRINTHEAD FAMILY & STRATEGIC PARTNERSHIP
1st Jun 20163:39 pmRNSTotal Voting Rights
19th May 20163:01 pmRNSResult of AGM - Replacement
18th May 20163:03 pmRNSResult of AGM
13th May 201610:09 amRNSGrant of Options
9th May 201612:42 pmRNSDirector Shareholding
4th May 20167:00 amRNSAppointment of Non-Executive Director
29th Apr 20169:00 amRNSTotal Voting Rights
15th Apr 20169:59 amRNSDirector/PDMR Shareholding - SIP Purchase
5th Apr 20163:17 pmRNSHolding(s) in Company
4th Apr 20161:58 pmRNSGrant of Options
1st Apr 20161:50 pmRNSHolding(s) in Company
1st Apr 20169:03 amRNSTotal Voting Rights
22nd Mar 201612:04 pmRNSXAAR LAUNCHES NEW FAMILY OF PRINTHEADS
18th Mar 201612:07 pmRNSDirector/PDMR Shareholding
16th Mar 20167:00 amRNS2015 Full Year Results, 2020 Vision
7th Mar 201610:00 amRNSHolding(s) in Company
1st Mar 201610:13 amRNSTotal Voting Rights
1st Feb 20162:41 pmRNSTotal Voting Rights
22nd Jan 201612:02 pmRNSHolding(s) in Company
18th Jan 20166:16 pmRNSHolding(s) in Company
13th Jan 20167:00 amRNSScheduled Trading Statement
6th Jan 20167:00 amRNSXAAR STRENGTHENS ITS 3D PRINTING BUSINESS
4th Jan 20164:12 pmRNSBlocklisting Interim Review
4th Jan 20163:27 pmRNSTotal Voting Rights
17th Dec 201510:07 amRNSDirector Shareholding
11th Dec 20157:00 amRNSBoard Changes
9th Dec 20154:56 pmRNSHolding(s) in Company
1st Dec 20155:52 pmRNSTotal Voting Rights
25th Nov 20153:46 pmRNSHolding(s) in Company
16th Nov 20159:50 amRNSHolding(s) in Company
9th Nov 20151:53 pmRNSDirector/PDMR Shareholding
4th Nov 20157:00 amRNSInterim Management Statement
2nd Nov 20152:43 pmRNSTotal Voting Rights
7th Oct 20157:00 amRNSNotice of Trading Statement
1st Oct 201510:42 amRNSTotal Voting Rights
1st Sep 20152:43 pmRNSTotal Voting Rights
28th Aug 20153:44 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.